News
24/06/08

Obtention of the market authorization in Germany for Oralair® Grasses

Stallergenes has been granted with the market authorization in Germany for...

[more]
23/06/08

2 new websites for the Stallergenes group

Czech Republic and Slovakia had their own websites which is provided...

[more]
30/05/08

Stallergenes Poland launches its internet website

Stallergenes announces the launch of its Poland-based operations’...

[more]

This website is accredited by Health On the Net Foundation. Click to verify.

We comply with the HONcode standard for trustworthy health information: verify here.

Last update: 24/06/2008

 

 

STALLERGENES is a European biopharmaceutical laboratory specialising in the treatment by desensitisation of allergy-related respiratory conditions.

The Group's activities focus on research into allergy, and the development, production and distribution of allergen extracts for the curative treatment of allergic rhinitis and asthma.